Sorry, you need to enable JavaScript to visit this website.

ELLENCE® (epirubicin HCl) Indications and Usage

1 INDICATIONS AND USAGE

ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer [see Clinical Studies (14.1)].

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No